Photographic review of results from a clinical study comparing benzoyl peroxide 5%/clindamycin 1% topical gel with vehicle in the treatment of rosacea

Cutis

Volumn 73, Issue 6 SUPPL., 2004, Pages 11-17

  Leyden, James J ^{a,d,e,f,g,h,i,j,k,l,m}   Thiboutot, Diane ^b,g   Shalita, Alan ^{c,d,g,i,j,m,n}  

^a Skin Study Center   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d ALLERGAN INC   (United States)

^e Managed Care and Professional Affairs   (United States)

^f Bradley Pharmaceuticals Inc   (United States)

^g Dermik Laboratories   (United States)

^h ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

ⁱ Galderma Laboratories   (United States)

^j The Dermatology Company   (United States)

^k Ortho McNeil Pharmaceutical Incorporated   (United States)

^l Roche Pharmaceuticals   (United Kingdom)

^m Strakan ^*

ⁿ Stiefel Laboratories

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENZOYL CHLORIDE PLUS CLINDAMYCIN; BENZOYL PEROXIDE; CLINDAMYCIN; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; PAPULE; PHOTOGRAPHY; PUSTULE; RANDOMIZATION; RELIABILITY; REVIEW; ROSACEA; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; CLINDAMYCIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; NEW YORK; PENNSYLVANIA; ROSACEA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 3042568995     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Blount BW, Pelletier AL. Rosacea: a common, yet commonly overlooked, condition. Am Fam Physician. 2002;66:435-440.
2. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society expert committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002;46:584-537.
3. McDonnell JK, Tomecki KJ. Rosacea: an update. Cleve Clin J Med. 2000;67:587-590.
4. Nielson PG. The relapse rate for rosacea after treatment with either oral tetracycline or metronidazole cream [letter]. Br J Dermatol. 1983;109:122.
5. Wilkin JK, DeWitt S. Treatment of rosacea: topical clindamycin versus oral tetracycline. Int J Dermatol. 1993;32:65-67.
6. Torresani C, Pavesi A, Manara GC. Clarithromycin versus doxycycline in the treatment of rosacea. Int J Dermatol. 1997;36:942-946.
7. Bikowski JB. Treatment of rosacea with doxycycline monohydrate. Cutis. 2000;66:149-152.
8. Dobson RL, Belknap BS. Topical erythromycin solution in acne, results of a multiclinic trial. J Am Acad Dermatol. 1980;3:478-482.
9. Becker LE, Bergstresser PR, Whiting DA, et al. Topical clindamycin therapy for acne vulgaris. a cooperative clinical study. Arch Dermatol. 1981;117:482-485.
10. Lesher JL Jr, Chalker DK, Smith JG Jr, et al. An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris. J Am Acad Dermatol. 1985;12:526-531.
11. Pochi PE, Bagatell FK, Ellis CN, et al. Erythromycin 2 percent gel in the treatment of acne vulgaris. Cutis. 1988;41:132-136.
12. Ellis CN, Gammon WR, Stone DSZ, et al. A comparison of Cleocin T Solution, Cleocin T Gel, and placebo in the treatment of acne vulgaris. Cutis. 1988;42:245-247.
13. Ellis CN, Leyden J, Katz HI, et al. Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris. Cutis. 2001;67(suppl 2):13-20.
14. Leyden JJ, Berger RS, Dunlap FE, et al. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and placebo gel in the treatments of acne vulgaris. Am J Clin Dermatol. 2001;2:33-39.
15. Leyden JJ, Hickman JG, Jarratt MT, et al. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. J Cutan Med Surg. 2001;5:37-42.
16. Tschen EH, Katz HI, Jones TM, et al. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and placebo in the treatment of acne vulgaris. Cutis. 2001;67:165-169.
17. Breneman D, Savin R, VandePol C, et al. Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea. Int J Dermatol. 2004;43:381-387.
18. Plewig G, Kligman AM. Acne and Rosacea. Berlin, Germany: Springer Verlag; 2000.